These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15642547

  • 1. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.
    Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS, Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators.
    Am J Cardiol; 2005 Jan 15; 95(2):173-7. PubMed ID: 15642547
    [Abstract] [Full Text] [Related]

  • 2. Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy.
    Kirtane AJ, Heyman ER, Metzger C, Breall JA, Carrozza JP.
    JACC Cardiovasc Interv; 2008 Apr 15; 1(2):186-91. PubMed ID: 19463299
    [Abstract] [Full Text] [Related]

  • 3. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).
    Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ.
    Am J Cardiol; 2010 Apr 15; 105(8):1060-4. PubMed ID: 20381653
    [Abstract] [Full Text] [Related]

  • 4. Acute and mid-term local vascular effects of compliant balloon inflation (GuardWire system) on saphenous vein bypass grafts: an angiographic analysis.
    Agostoni P, Vermeersch P, Vydt T, Debrauwere J, Van den Heuvel P, Convens C, Van den Branden F, Verheye S, Van Langenhove G.
    Int J Cardiol; 2007 Aug 21; 120(2):227-31. PubMed ID: 17175046
    [Abstract] [Full Text] [Related]

  • 5. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
    Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L.
    Circulation; 2008 Feb 12; 117(6):790-7. PubMed ID: 18212287
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
    Cohen DJ, Murphy SA, Baim DS, Lavelle TA, Berezin RH, Cutlip DE, Ho KK, Kuntz RE, SAFER Trial Investigators.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1801-8. PubMed ID: 15519010
    [Abstract] [Full Text] [Related]

  • 7. Inadvertent dilation of a saphenous vein graft stenosis by the PercuSurge GuardWire distal protection balloon.
    Sharma N, Kalaria VG.
    Catheter Cardiovasc Interv; 2003 Jul 02; 59(3):346-9. PubMed ID: 12822155
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
    Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, FilterWire EX Randomized Evaluation Investigators.
    Circulation; 2003 Aug 05; 108(5):548-53. PubMed ID: 12874191
    [Abstract] [Full Text] [Related]

  • 9. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
    Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE, AMEthyst Study Investigators.
    JACC Cardiovasc Interv; 2008 Jun 05; 1(3):248-57. PubMed ID: 19463308
    [Abstract] [Full Text] [Related]

  • 10. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
    Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C.
    J Am Coll Cardiol; 2007 Oct 09; 50(15):1442-9. PubMed ID: 17919563
    [Abstract] [Full Text] [Related]

  • 11. A prospective multicenter registry of laser therapy for degenerated saphenous vein graft stenosis: the COronary graft Results following Atherectomy with Laser (CORAL) trial.
    Giugliano GR, Falcone MW, Mego D, Ebersole D, Jenkins S, Das T, Barker E, Ruggio JM, Maini B, Bailey SR.
    Cardiovasc Revasc Med; 2012 Oct 09; 13(2):84-9. PubMed ID: 22406059
    [Abstract] [Full Text] [Related]

  • 12. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
    Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE, Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators.
    Circulation; 2002 Mar 19; 105(11):1285-90. PubMed ID: 11901037
    [Abstract] [Full Text] [Related]

  • 13. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
    Halkin A, Masud AZ, Rogers C, Hermiller J, Feldman R, Hall P, Haber RH, Cambier PA, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, Mehran R, Stone GW.
    Am Heart J; 2006 Apr 19; 151(4):915.e1-7. PubMed ID: 16569562
    [Abstract] [Full Text] [Related]

  • 14. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
    Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure R, Moliterno D.
    Catheter Cardiovasc Interv; 2007 Apr 01; 69(5):623-9. PubMed ID: 17192960
    [Abstract] [Full Text] [Related]

  • 15. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris.
    Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER, Toegel G, Kuchela A, Woupio A, Kuntz RE, Macon ND.
    Circulation; 2004 Apr 13; 109(14):1735-40. PubMed ID: 15066954
    [Abstract] [Full Text] [Related]

  • 16. Export aspiration catheter-enhanced FilterWire delivery: an innovative strategy for treatment of saphenous vein graft disease.
    Jim MH, Ho HH, Chow WH.
    J Invasive Cardiol; 2006 Nov 13; 18(11):569-74. PubMed ID: 17090825
    [Abstract] [Full Text] [Related]

  • 17. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts.
    Liu MW, Douglas JS, Lembo NJ, King SB.
    Am J Cardiol; 1993 Sep 01; 72(7):514-7. PubMed ID: 8362763
    [Abstract] [Full Text] [Related]

  • 18. Applicability of distal protection for aortocoronary vein graft interventions in clinical practice.
    Mathew V, Lennon RJ, Rihal CS, Bresnahan JF, Holmes DR.
    Catheter Cardiovasc Interv; 2004 Oct 01; 63(2):148-51. PubMed ID: 15390255
    [Abstract] [Full Text] [Related]

  • 19. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
    Magee MJ, Alexander JH, Hafley G, Ferguson TB, Gibson CM, Harrington RA, Peterson ED, Califf RM, Kouchoukos NT, Herbert MA, Mack MJ, PREVENT IV Investigators.
    Ann Thorac Surg; 2008 Feb 01; 85(2):494-9; discussion 499-500. PubMed ID: 18222251
    [Abstract] [Full Text] [Related]

  • 20. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
    Olenchock SA, Karmpaliotis D, Gibson WJ, Murphy SA, Southard MC, Ciaglo L, Buros J, Mack MJ, Alexander JH, Harrington RA, Califf RM, Kouchoukos NT, Ferguson TB, Gibson CM.
    Ann Thorac Surg; 2008 Feb 01; 85(2):520-4. PubMed ID: 18222256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.